These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26971194)

  • 1. A comparison of regional and general anesthesia effects on 5 year survival and cancer recurrence after transurethral resection of the bladder tumor: a retrospective analysis.
    Jang D; Lim CS; Shin YS; Ko YK; Park SI; Song SH; Kim BJ
    BMC Anesthesiol; 2016 Mar; 16():16. PubMed ID: 26971194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal Anesthesia is Associated with Lower Recurrence Rates after Resection of Nonmuscle Invasive Bladder Cancer.
    Koumpan Y; Jaeger M; Mizubuti GB; Tanzola R; Jain K; Hosier G; Hopman W; Siemens DR
    J Urol; 2018 Apr; 199(4):940-946. PubMed ID: 29154849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
    Skolarikos A; Chrisofos M; Ferakis N; Papatsoris A; Dellis A; Deliveliotis C
    J Urol; 2005 Jun; 173(6):1908-11. PubMed ID: 15879773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era.
    Takaoka E; Matsui Y; Inoue T; Miyazaki J; Nakashima M; Kimura T; Oikawa T; Kawai K; Yoshimura K; Habuchi T; Ogawa O; Nishiyama H
    Jpn J Clin Oncol; 2013 Apr; 43(4):404-9. PubMed ID: 23444116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
    Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
    BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shorter recurrence-free survival time, higher risk of multiple recurrences: a retrospective study of non-muscle invasive bladder cancer after transurethral resection.
    Deng N; Chen JX; Chen LW; Qiu SP; Li XF; Wang DH
    Chin Med J (Engl); 2012 Oct; 125(20):3681-6. PubMed ID: 23075724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate: a comparative retrospective study.
    Jaidane M; Bouicha T; Slama A; Hmida W; Hidoussi A; Ben Sorba N; Mosbah F
    Urology; 2010 Jun; 75(6):1392-5. PubMed ID: 19781747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in anesthetic considerations for arteriovenous fistula creation.
    Siracuse JJ; Gill HL; Parrack I; Huang ZS; Schneider DB; Connolly PH; Meltzer AJ
    J Vasc Access; 2014; 15(5):364-9. PubMed ID: 24811604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of the efficacy, safety, and cost-effectiveness of fulguration under local anesthesia for small-sized recurrent masses: a comparative analysis to transurethral resection of bladder tumors in a matched cohort.
    Park DS; Hwang JH; Gong IH; Choi DK; Kang MH; Oh JJ
    J Endourol; 2013 Oct; 27(10):1240-4. PubMed ID: 23964922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
    Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
    Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
    Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H
    Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional versus general anesthesia in surgical patients with chronic obstructive pulmonary disease: does avoiding general anesthesia reduce the risk of postoperative complications?
    Hausman MS; Jewell ES; Engoren M
    Anesth Analg; 2015 Jun; 120(6):1405-12. PubMed ID: 25526396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ-sparing treatment in muscle-invasive bladder cancer.
    Dunst J; Diestelhorst A; Kühn R; Müller AC; Scholz HJ; Fornara P
    Strahlenther Onkol; 2005 Oct; 181(10):632-7. PubMed ID: 16220401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paravertebral Block Does Not Reduce Cancer Recurrence, but Is Related to Higher Overall Survival in Lung Cancer Surgery: A Retrospective Cohort Study.
    Lee EK; Ahn HJ; Zo JI; Kim K; Jung DM; Park JH
    Anesth Analg; 2017 Oct; 125(4):1322-1328. PubMed ID: 28857802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
    Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
    J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing recurrence in non-muscle-invasive bladder cancer using photodynamic diagnosis and immediate post-transurethral resection of the bladder chemoprophylaxis.
    Lykke MR; Nielsen TK; Ebbensgaard NA; Zieger K
    Scand J Urol; 2015 Jun; 49(3):230-6. PubMed ID: 25731785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Hagiwara M; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Hasegawa S; Nakajima Y; Oya M
    Ann Surg Oncol; 2014 Sep; 21(9):3151-8. PubMed ID: 24682698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.